AI assistant
Sending…
AMICUS THERAPEUTICS, INC. — Director's Dealing 2014
Feb 13, 2014
31523_dirs_2014-02-13_1969776d-59df-4bb8-b9c4-2d8ee089321a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2013-12-31
Reporting Person: Crowley John F (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-20 | Common Stock | G | 117925 | $0.00 | Disposed | 15484 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64895 | Indirect |
Footnotes
F1: Mr. Crowley transferred 117,925 shares to the John F. Crowley Charitable Lead Annuity Trust at the University of Notre Dame.
More from AMICUS THERAPEUTICS, INC.
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27